Member Info for hazrat

Ebitda margin wasn't it?

Doubt it. The big hope here is autonomy issues are resolved, company dual lists in the US and the valuation goes through the roof. Look at what happened to GW Pharma that did the same.

OK so some excuses out the way but the uncertainty is still material.

How are brexit excuses out the way? We haven't left and haven't negotiated a trade arrangement. Brexit is just getting started.

I agree Steve, exactly as signalled and so no great surprise. Positive dividend continues to increase and once restructure is finalised, should be well positioned to grow.

Mailman you logic confounds me. Would it have been better to falsely think GTN was the activ?

Good find, thanks

PATS we are in accord. I took umbrage at what I thought was a deliberate attempt on your part to mislead people and for that I apologise.

Zwarts, you normally talk such sense but I also know you like to tease and so I take your comment in jest.

Where has Ananda gone? He fought the good fight from 40p down to 8 but now seems to have called it a day

Hardly insults PATS, not the same as calling someone a moron.

Please point out a single insult.

Thanks Bucolic, great that some reasonable people still follow this company.

PATS face it, you don't have a clue what is going on here and that is why you throw insults when your deficiencies are called out. You suggested that the general meeting had been called for a surprise announcement which is total rubbish for many reasons. I get that you are embarrassed but no need to be rude.

I haven't ramped or deramped this share. I don't think one needs to either be in one camp or the other. It is actually possible to take a balanced view and comment on both the risks and opportunities. I have serious reservations and a total lack of trust in management. However, dermasys does look like it works and so there is huge potential here. So we have terrible management, a vague strategy with many hurdles to overcome but a product that could be a game changer and make a lot of money. Interesting position to be in.

Says PATS who doesn't even know why the general meeting has been called. Obviously well clued up. Best take his/her advice

Not really asking PATS because it definitely is.

Isn't that to approve the placing?

Wow wow wow, don't blame me. I am delighted for all by the rise and it caught me off guard as well. I hope it continues and that management finally, after years of false starts, manage to deliver.

Thanks, sounds about right

Money for 12 months if no more trials needed. Hardly removes uncertainty

Think the CEO used to work in finance so he has no excuse.

A very garbled RNS.

At one point they say "Futura's proprietary transdermal formulation DermaSys® clinically proven to treat Erectile Dysfunction" which is excellent. However, later on it is qualified by "in the Board's opinion". Surely it is either proven or it isn't?

They now claim that the phase 3 hit all primary end points, having said on the 10th that it didn't. I wonder if the SP would be where it is now if they had got the messaging right back then. Exactly the same mistake Immupharma made and I said a while back that I hoped these idiots wouldn't repeat. They really are idiots.

Funding will only last for 12 months of no further studies are required so high potential for further placings, especially given how incompetent management are.

Even just a date for interim results would be nice